|
Citation
|
Schnakers C, Divine J, Johnson MA, Lutkenhoff E, Monti MM, Keil KM, Guthrie J, Pouratian N, Patterson D, Jensen G, Morales VC, Weaver KF, Rosario ER. Brain Inj. 2021; ePub(ePub): ePub. |
|
Abstract
|
OBJECTIVES: This longitudinal study aims at 1) providing preliminary evidence of changes in blood-based biomarkers across time in chronic TBI and 2) relating these changes to outcome measures and cerebral structure and activity.
METHODS: Eight patients with moderate-to-severe TBI (7 males, 35 ± 7.6 years old, 5 severe TBI, 17.52 ± 3.84 months post-injury) were evaluated at monthly intervals across 6 time-points using: a) Blood-based biomarkers (GFAP, NSE, S100A12, SDBP145, UCH-L1, T-tau, P-tau, P-tau/T-tau ratio); b) Magnetic Resonance Imaging to evaluate changes in brain structure; c) Resting-state electroencephalograms to evaluate changes in brain function; and d) Outcome measures to assess cognition, emotion, and functional recovery (MOCA, RBANS, BDI-II, and DRS).
RESULTS: Changes in P-tau levels were found across time [p = .007]. P-tau was positively related to functional [p < .001] and cognitive [p = .006] outcomes, and negatively related to the severity of depression, 6 months later [R = -0.901; p =.006]. P-tau and P-tau/T-tau ratio were also positively correlated to shape change in subcortical areas such as brainstem [T(7) = 4.71, p = .008] and putamen [T(7) = 3.25, p = .012].
CONCLUSIONS: Our study provides preliminary findings that suggest a positive relationship between P-tau and the recovery of patients with chronic TBI.
Language: en |